Baystate Wealth Management’s Celgene Corp CELG Stock Holding History

Baystate Wealth Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-150	Closed	-$15K	–	695
2019 Q3	$15K	Hold	150	–	–	﹤0.01%	325
2019 Q2	$14K	Sell	150 -140	-48%	-$13.3K	﹤0.01%	338
2019 Q1	$27K	Sell	290 -18	-6%	-$1.57K	﹤0.01%	280
2018 Q4	$27K	Sell	308 -326	-51%	-$24.1K	﹤0.01%	278
2018 Q3	$53K	Hold	634	–	–	0.01%	196
2018 Q2	$53K	Hold	634	–	–	0.01%	186
2018 Q1	$57K	Hold	634	–	–	0.01%	180
2017 Q4	$65K	Buy	634 +52	+9%	+$5.87K	0.01%	176
2017 Q3	$81K	Hold	582	–	–	0.01%	142
2017 Q2	$78K	Sell	582 -300	-34%	-$36.8K	0.01%	138
2017 Q1	$110K	Hold	882	–	–	0.02%	111
2016 Q4	$105K	Buy	+882	New	+$98.2K	0.02%	100
2013 Q3	–	Sell	-14,566	Closed	-$852K	–	282
2013 Q2	$852K	Buy	+14,566	New	+$877K	0.42%	22

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Baystate Wealth Management's CELG Position: Q4 2019 in Review

Baystate Wealth Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 150 shares — an estimated $15K sold.

Baystate Wealth Management first reported a position in CELG in Q2 2013 and held it in 13 quarters. The position peaked at $852K in Q2 2013. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Baystate Wealth Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Baystate Wealth Management sold 150 Celgene Corp shares in Q4 2019, an estimated $15K.
Baystate Wealth Management first reported a position in Celgene Corp in Q2 2013 and held it in 13 quarters.
Baystate Wealth Management's Celgene Corp position peaked at $852K in Q2 2013.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Baystate Wealth Management's 13F filing for Q4 2019, filed 21 Jan 2020.